Portfolio
cichlid has initiated many biotech ventures and has evolved together since its founding in 2014.
-
BitD Inc.New biomarker-based innovative antibodies through clinical and translational research -
Cubelabs Inc.Manufactures a customized medical device based on 3D printing technology, making patients' life back to the dynamic.Cubelabs Inc.Manufactures a customized medical device based on 3D printing technology, making patients' life back to the dynamic.- Year2016
- Fieldcustomized medical device manufacturing
- LocationGangneung, Korea
- Websitehttp://www.cubelabs.co.kr/
-
Deep Bio Inc.Using deep learning technology, develops pathology diagnostic software for detecting the presence and severity of cancer and predicting the prognosis of cancer from digital images of tissuesDeep Bio Inc.Using deep learning technology, develops pathology diagnostic software for detecting the presence and severity of cancer and predicting the prognosis of cancer from digital images of tissues- Year2015
- FieldAI-based cancer diagnostics & prognostics software
- LocationSeoul, Korea
- Websitehttps://deepbio.co.kr/
-
OpenCare Inc.Builds a healthcare community, open and easy to participateOpenCare Inc.Builds a healthcare community, open and easy to participate- Year2018
- FieldMedical Data Software
- LocationSeoul, Korea
- Websitehttps://www.opencare.co.kr
-
Xcell Therapeutics Inc.Innovative cell culture media provider who developed the world's first chemically defined media for human mesenchymal stem cellsXcell Therapeutics Inc.Innovative cell culture media provider who developed the world's first chemically defined media for human mesenchymal stem cells- Year2015 (IPO 2024)
- FieldCell culture media
- LocationSeoul, Korea
- Websitehttp://xcell.media/
-
GenoBio Corp.The Most Advanced Integrated Liquid-Biopsy (LBx) PLATFORM DEVELOPMENTGenoBio Corp.The Most Advanced Integrated Liquid-Biopsy (LBx) PLATFORM DEVELOPMENT- Year2014
- FieldDiagnostics platform device
- LocationSeoul, Korea
- Websitehttps://www.genobio.co.kr/
-
Genopharm Inc.Develops interferon-beta based immunocytokine oncology therapeuticsGenopharm Inc.Develops interferon-beta based immunocytokine oncology therapeutics- Year2017
- FieldImmuno-oncology drug
- LocationSeoul, Korea
- Websitehttp://www.genopharmbio.com
-
CARotsDevelops ‘Off-the-shelf’ CAR-NK Therapy